During severe acute or chronic illness, protein wasting occurs and is associated with increased morbidity and mortality from muscle wasting and impaired immune function. Preservation of body protein under such circumstances may have clinical importance. The overall purpose of these studies is to test the hypothesis that glutamine has a protein anabolic effect in humans. Although glutamine is the most abundant amino acid in the body and can be synthesized de novo, muscle free glutamine pool can be depleted with stress and protein wasting diseases, and replenishment of the glutamine stores is associated with improved nitrogen balance in such conditions. Using isotopic techniques developed in our lab, we have obtained preliminary data suggesting that in healthy humans: 1) 30-5O% of glutamine turnover is either partially or totally oxidized; 2) the splanchnic bed is a prominent site of glutamine uptake; and 3) enteral glutamine acutely decreases the rate of whole body leucine oxidation and increases nonoxidative leucine disposal (NOLD), an index of whole body protein synthesis. The direction and magnitude of glutamine's anabolic effect were similar to those described with growth hormone (GH) administration; yet it remains to be established whether the anabolic effect of glutamine is mediated by GH. Conversely, although glutamine has the highest concentration of all amino acids in plasma, it is not known whether acute decreases in plasma glutamine concentration cause protein catabolism. Finally, it remains to be determined whether glutamine can stimulate protein synthesis under conditions of hypercatabolism such as that induced by glucocorticoids. The proposed studies will use infusions of stable and radioactive tracers of leucine and glutamine to determine in vivo in healthy humans: 1) whether glutamine stimulates GH secretion; 2) whether an acute decrease in plasma glutamine concentration--induced by the drug phenylbutyrate--has a protein catabolic effect; 3) whether enteral glutamine can alter the catabolic response to glucocorticoids; and 4) whether an acute decrease in plasma glutamine concentration enhances the protein catabolic response to glucocorticoids. These studies will expand our understanding of the physiologic role of glutamine in protein metabolism. In addition, should these studies provide evidence for an anabolic role of glutamine in humans, they would support the use of enteral or parenteral glutamine supplementation as an effective, inexpensive means of preserving body protein stores, and, potentially, decrease the morbidity and mortality of severe illness.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK051477-03
Application #
2518554
Study Section
Metabolism Study Section (MET)
Program Officer
May, Michael K
Project Start
1995-09-30
Project End
1999-08-31
Budget Start
1997-09-01
Budget End
1999-08-31
Support Year
3
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Nemours Foundation
Department
Type
DUNS #
City
Jacksonville
State
FL
Country
United States
Zip Code
32246
Thibault, Ronan; Welch, Susan; Mauras, Nelly et al. (2008) Corticosteroids increase glutamine utilization in human splanchnic bed. Am J Physiol Gastrointest Liver Physiol 294:G548-53
Le Bacquer, Olivier; Mauras, Nelly; Welch, Susan et al. (2007) Acute depletion of plasma glutamine increases leucine oxidation in prednisone-treated humans. Clin Nutr 26:231-8
Meynial-Denis, Dominique; Verdier, Lionel; Mignon, Michelle et al. (2005) Does acute glutamine depletion enhance the response of glutamine synthesis to fasting in muscle in adult and old rats? Clin Nutr 24:398-406
Humbert, B; Le Bacquer, O; Nguyen, P et al. (2001) Protein restriction and dexamethasone as a model of protein hypercatabolism in dogs: effect of glutamine on leucine turnover. Metabolism 50:293-8
Hankard, R G; Haymond, M W; Darmaun, D (2000) Role of glucose in the regulation of glutamine metabolism in health and in type 1 insulin-dependent diabetes. Am J Physiol Endocrinol Metab 279:E608-13
Marchini, J S; Nguyen, P; Deschamps, J Y et al. (1999) Effect of intravenous glutamine on duodenal mucosa protein synthesis in healthy growing dogs. Am J Physiol 276:E747-53
Hankard, R (1998) Duchenne muscular dystrophy: a model for studying the contribution of muscle to energy and protein metabolism. Reprod Nutr Dev 38:181-6
Darmaun, D; Welch, S; Rini, A et al. (1998) Phenylbutyrate-induced glutamine depletion in humans: effect on leucine metabolism. Am J Physiol 274:E801-7
Hankard, R G; Hammond, D; Haymond, M W et al. (1998) Oral glutamine slows down whole body protein breakdown in Duchenne muscular dystrophy. Pediatr Res 43:222-6
Menand, C; Pouteau, E; Marchini, S et al. (1997) Determination of low 13C-glutamine enrichments using gas chromatography-combustion-isotope ratio mass spectrometry. J Mass Spectrom 32:1094-9